Skip to main content

Publisher: Wiley-Blackwell

Volume 36, Number 3, September 2008

Introduction: Facts and Fictions: BiDil and the Resurgence of Racial Medicine
pp. 443-448(6)
Authors: Dorr, Gregory Michael; Jones, David S.

Favourites:
ADD

Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients
pp. 449-457(9)
Authors: Ellison, George T. H.; Kaufman, Jay S.; Head, Rosemary F.; Martin, Paul A.; Kahn, Jonathan D.

Favourites:
ADD

Genotyping the Future: Scientists’ Expectations about Race/ Ethnicity after BiDil
pp. 464-470(7)
Authors: Tutton, Richard; Smart, Andrew; Martin, Paul A.; Ashcroft, Richard; Ellison, George T. H.

Favourites:
ADD
Favourites:
ADD

“Special Treatment”: BiDil, Tuskegee, and the Logic of Race
pp. 478-484(7)
Author: Reverby, Susan M.

Favourites:
ADD

Popular Representations of Race: The News Coverage of BiDil
pp. 485-490(6)
Authors: Caulfield, Timothy; Harry, Simrat

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Research on Medical Records Without Informed Consent
pp. 560-566(7)
Author: Miller, Franklin G.

Favourites:
ADD

Rethinking Risk in Pediatric Research
pp. 567-576(10)
Authors: Glass, Kathleen Cranley; Binik, Ariella

Favourites:
ADD

Currents in Contemporary Ethics
pp. 585-588(4)
Author: Payne, Perry W.

Favourites:
ADD

Teaching Health Law
pp. 589-593(5)
Author: Lombardo, Paul A.

Favourites:
ADD

Recent Developments in Health Law
pp. 594-594(1)
Author: Jacobstein, Jeffrey M.

Favourites:
ADD

Calendar of Events
pp. 602-602(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more